4.3 Article

Follow-up of the Post-Liver Transplantation Patient A Primer for the Practicing Gastroenterologist

期刊

CLINICS IN LIVER DISEASE
卷 21, 期 4, 页码 793-813

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cld.2017.06.006

关键词

Liver transplantation; Immunosuppression; Outcomes; Prophylaxis; Screening

资金

  1. Novartis
  2. Abbvie

向作者/读者索取更多资源

The focus in liver transplantation in the next 10 years will likely change from preventing viral disease recurrence to minimizing the toll of rejection and fatty liver disease, minimizing the complications from immunosuppression with withdrawal strategies, and more optimal management of long-term risks, such as malignancy, cardiovascular disease, and renal failure. In addition, now that short-term results (< 1 year) have improved significantly, there will be a shift toward improving long-term patient and graft survival, as well as a focus on primary care preventive strategies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据